Skip to main content Accessibility help
×
Home
Hostname: page-component-544b6db54f-2p87r Total loading time: 2.303 Render date: 2021-10-19T03:54:13.848Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Sulthiame

Published online by Cambridge University Press:  01 June 2018

Philip N. Patsalos
Affiliation:
UCL Institute for Neurology
Erik K. St Louis
Affiliation:
Mayo Clinic
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ben-Zeev, B, Watemberg, N, Lerman, P, Barash, I, Brand, N, Lerman-Sagie, T. Sulthiame in childhood epilepsy. Pediatric International 2004; 46: 521524.CrossRefGoogle ScholarPubMed
Borusiak, P, Langer, T, Heruth, M, Karenfort, M, Bettendorf, U, Jenke, AC. Antiepileptic drugs and bone metabolism in children: data from 128 patients. Journal of Child Neurology 2013; 28: 176183.CrossRefGoogle ScholarPubMed
Debus, OM, Kurlemann, G; Study group. Sulthiame in the primary therapy of West syndrome: a randomized double-blind placebo-controlled add-on trial on baseline pyridoxine medication. Epilepsia 2004; 45: 103108.CrossRefGoogle ScholarPubMed
Doose, H, Baier, WK, Ernst, JP, Tuxhorn, I, Volzke, E. Benign partial epilepsy: treatment with sulthiame. Developmental Medicine and Child Neurology 1988; 30: 683684.CrossRefGoogle ScholarPubMed
Fejerman, N, Caraballo, R, Cersósimo, R, Ferraro, SM, Galicchio, S, Amartino, H. Sulthiame add-on therapy in children with focal epilepsies associated with encephalopathy related to electrical status epilepticus during slow sleep (ESES). Epilepsia 2012; 53: 11561161.CrossRefGoogle Scholar
Freilinger, M, Seidl, R, Hauser, E. Carbamazepine, oxcarbazepine and sulthiame in newly diagnosed benign epilepsy of childhood with rolandic spikes. Epilepsia 1997; 38(Suppl 3): 9798.Google Scholar
Houghton, GW, Richens, A. Inhibition of phenytoin metabolism by sulthiame. British Journal of Pharmacology 1973; 49: 157158.Google ScholarPubMed
Huppke, P, Kohler, K, Brockmann, K, Stettner, GM, Gartner, J. Treatment of epilepsy in Rett syndrome. European Journal of Paediatric Neurology 2007; 11: 1016.CrossRefGoogle ScholarPubMed
Koepp, MJ, Patsalos, PN, Sander, JWAS. Sulthiame in adults with refractory epilepsy and learning disability: an open trial. Epilepsy Research 2002; 50: 277282.CrossRefGoogle ScholarPubMed
Kramer, U, Shahar, E, Zelnik, N, Lerman-Sagie, T, Watemberg, N, Nevo, Y, Ben-Zeev, B. Carbamazepine versus sulthiame in treating benign childhood epilepsy with centrotemporal spikes. Journal of Child Neurology 2002; 17: 914916.CrossRefGoogle ScholarPubMed
Lerman, P, Nussbaum, E. The use of sulthiame in myoclonic epilepsy of childhood and adolescence. Acta Neurologica Scandinavica 1975: 60 (Suppl): 712.CrossRefGoogle ScholarPubMed
May, TW, Korn-Merker, E, Rambeck, B, Boenigk, HE. Pharmacokinetics of sulthiame in epileptic patients. Therapeutic Drug Monitoring 1994; 16: 251257.CrossRefGoogle ScholarPubMed
Rating, D, Wolf, C, Bast, T. Sulthiame as monotherapy in children with benign childhood epilepsy with centrotemporal spikes: a 6-month randomized, double-blind, placebo-controlled study. Sulthiame Study Group. Epilepsia 2000; 41: 12841288.CrossRefGoogle ScholarPubMed
Shamdeen, MG, Jost, W, Frohnhöfer, M, Gortner, L, Meyer, S. Effect of sulthiame on EEG pathology, behavior and school performance in children with Rolandic epileptiform discharges. Pediatric International 2012; 54: 798800.CrossRefGoogle ScholarPubMed
Tan, HJ, Singh, J, Gupta, R, de Gpede, C. Comparison of antiepileptic drugs, no treatment, or placebo for children with benign epilepsy with centro temporal spikes. Cochrane Database Systematic Reviews 2014; (9): CS06779Google ScholarPubMed
Wirrell, E, Sherman, EM, Vanmastigt, R, Hamiwka, L. Deterioration in cognitive function in children with benign epilepsy of childhood with centro temporal spikes treated with sulthiame. Journal of Child Neurology 2008; 23: 1421.CrossRefGoogle Scholar

Send book to Kindle

To send this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Send book to Dropbox

To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to Dropbox.

Available formats
×

Send book to Google Drive

To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to Google Drive.

Available formats
×